Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 50.07 3.82% 1.84
GBT closed up 3.82 percent on Monday, October 21, 2019, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Nov 4

*** please verify all earnings dates ***
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical GBT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 20 DMA Bearish 3.82%
Fell Below 50 DMA Bearish 3.82%
Crossed Above 20 DMA Bullish 1.03%
Crossed Above 50 DMA Bullish 1.03%

Older signals for GBT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
GBT Chart by TradingView
Basic chart:
Profile
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Medicine Biopharmaceutical Medical Specialties Blood Sickle Cell Disease Hereditary Angioedema Angioedema Hemoglobin Hemoglobins
Is GBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 21 GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor
Oct 18 These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year
Oct 14 Global Blood Therapeutics: A Core Biotech Buy For Patient Investors
Oct 2 GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention
Oct 1 GBT to Host Analyst & Investor Day on October 8 in New York
Sep 25 GBT Announces Participation at the 2019 Cantor Global Healthcare Conference
Sep 19 When Will Loss-Maker Global Blood Therapeutics, Inc. (NASDAQ:GBT) Need More Cash?
Sep 11 3 Hot Biotechs with High Upside Potential
Sep 10 Global Blood Therapeutics (GBT) Investor Presentation - Slideshow
Sep 9 Global Blood Therapeutics: Stock Responds To Voxelotor Receiving Priority Review
See more GBT news...
Indicators
Indicator Value
52 Week High 64.94
52 Week Low 30.15
Average Volume 773,178
200-Day Moving Average 52.7226
50-Day Moving Average 49.2505
20-Day Moving Average 48.6103
10-Day Moving Average 47.7205
Average True Range 2.407
ADX 17.11
+DI 22.1666
-DI 22.2123
Chandelier Exit (Long, 3 ATRs ) 49.369
Chandelier Exit (Short, 3 ATRs ) 51.391
Upper Bollinger Band 53.3659
Lower Bollinger Band 43.8547
Percent B (%b) 0.65
BandWidth 19.566224
MACD Line -0.5634
MACD Signal Line -0.8446
MACD Histogram 0.2812
Fundamentals Value
Market Cap 2.19 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -20.35
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 55.13
Resistance 3 (R3) 54.85 52.88 54.28
Resistance 2 (R2) 52.88 51.60 53.02 54.00
Resistance 1 (R1) 51.48 50.80 52.18 51.76 53.72
Pivot Point 49.51 49.51 49.87 49.65 49.51
Support 1 (S1) 48.11 48.23 48.81 48.39 46.42
Support 2 (S2) 46.14 47.43 46.28 46.14
Support 3 (S3) 44.74 46.14 45.86
Support 4 (S4) 45.02